V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320003910 | 320005098 | 1.59 | 81.1 | Palliative (P) | 2016-02-17 | 2016-02-24 | CARBOPLATIN + RT | 02 | N | 320008585 | CARBOPLATIN + CETUXIMAB + FU |
| 320003911 | 320002395 | 1.66 | 74.2 | Curative (C) | null | 2017-07-09 | Trial Unspecified | N | N | 320008611 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003912 | 320002396 | 1.91 | 89 | Palliative (P) | 2018-01-03 | 2018-01-12 | CETUXIMAB + CISPLATIN + FU | 02 | N | 320008714 | CAPECITABINE + CISPLATIN |
| 320003913 | 320002397 | 1.67 | 90.3 | Palliative (P) | 2017-02-09 | 2017-02-16 | Cisplatin + Pemetrexed | N | N | 320008744 | TRIAL |
| 320003914 | 320002397 | 1.63 | 81 | Adjuvant (A) | 2014-07-07 | 2014-07-20 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN | Y | Y | 320008744 | CARBOPLATIN + ETOPOSIDE |
| 320003915 | 320002397 | 1.67 | 79.9 | Palliative (P) | null | 2018-05-16 | IMATINIB | N | N | 320008744 | GEMCITABINE + PACLITAXEL |
| 320003916 | 320002398 | 1.62 | 54 | Palliative (P) | null | 2016-03-14 | EOX | null | null | 320008799 | BEVACIZUMAB + CARBO + GEMCITABINE |
| 320003917 | 320002399 | 1.72 | 93.4 | Curative (C) | 2016-05-23 | 2016-06-08 | CARBOPLATIN + RT | N | N | 320008822 | CISPLATIN + GEMCITABINE |
| 320003918 | 320002400 | 1.68 | 66.6 | Adjuvant (A) | 2013-11-03 | 2013-11-07 | Cetuximab + Radiotherapy Load | N | N | 320008849 | CYCLOPHOSPHAMIDE |
| 320003919 | 320005100 | 1.71 | 103 | Palliative (P) | 2015-03-31 | 2015-04-05 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 320008851 | CETUXIMAB + RT |
| 320003920 | 320002401 | 1.76 | null | Palliative (P) | null | 2016-12-17 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | 320008864 | GEMCITABINE |
| 320003921 | 320002402 | null | 57 | Palliative (P) | 2015-07-24 | 2015-07-26 | Cisplatin + Vinorelbine (IV) | N | N | 320008875 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320003922 | 320002403 | 1.64 | null | Palliative (P) | 2015-04-05 | 2015-05-17 | ICON8 TRIAL | N | N | 320008880 | CISPLATIN + GEMCITABINE |
| 320003923 | 320002404 | 1.62 | 59 | Palliative (P) | 2017-10-08 | 2017-10-27 | Ipilimumab | N | N | 320008881 | ICON TRIAL |
| 320003924 | 320002404 | null | 79 | Neo-adjuvant (N) | 2015-01-25 | 2016-01-07 | null | 02 | N | 320008881 | PCV |
| 320003925 | 320002405 | 1.66 | 57.2 | Adjuvant (A) | 2017-02-21 | 2017-02-21 | CARBOPLATIN + RT | 02 | Y | 320009017 | CARBOPLATIN + RT |
| 320003926 | 320002406 | 1.72 | 98.9 | Curative (C) | 2014-09-27 | 2014-10-06 | ICON8B TRIAL | 01 | Y | 320009019 | IMATINIB |
| 320003927 | 320002407 | null | 65.2 | Neo-adjuvant (N) | 2018-02-24 | 2018-02-25 | Enzalutamide | 99 | null | 320009066 | TRIAL |
| 320003928 | 320002408 | null | 46.2 | Adjuvant (A) | 2015-06-11 | 2015-06-11 | Bevacizumab + Paclitaxel | N | N | 320009092 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 320003929 | 320002409 | 1.61 | 64.7 | Palliative (P) | 2018-02-04 | 2018-02-12 | Bevacizumab+Carbo+Pacliaxel | N | N | 320009166 | PACLITAXEL |
| 320003930 | 320002410 | 1.64 | 56 | Palliative (P) | 2016-10-01 | 2017-05-19 | CARBOPLATIN + FLUOROURACIL | 02 | N | 320009173 | CISPLATIN + GEMCITABINE |
| 320003931 | 320002410 | 1.57 | 136 | Curative (C) | 2017-01-01 | 2017-02-01 | CARBOPLATIN + RT | N | Y | 320009173 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 320003932 | 320002410 | 1.7 | 77 | Adjuvant (A) | 2016-12-27 | 2017-01-04 | Cisplatin + Docetaxel +Fluorouracil | Y | N | 320009173 | CETUXIMAB + RT |
| 320003933 | 320002410 | null | 120 | null | 2016-06-06 | 2016-06-06 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 320009173 | CETUXIMAB + RT |
| 320003934 | 320002410 | 1.81 | 76 | Neo-adjuvant (N) | 2017-03-06 | 2017-03-29 | Vinflunine | 2 | N | 320009173 | CARBO + FLUOROURACIL |
| 320003935 | 320002411 | 1.61 | null | Neo-adjuvant (N) | 2017-02-28 | 2017-03-10 | Carboplatin + Etoposide iv&po | N | N | 320009246 | CARBOPLATIN + RT |
| 320003936 | 320002412 | 1.7 | 105 | Palliative (P) | 2015-05-09 | 2015-05-09 | Cisplatin + Docetaxel +Fluorouracil | N | N | 320009247 | CAPECITABINE + OXALIPLATIN |
| 320003937 | 320002413 | 1.67 | 84.3 | Palliative (P) | 2016-09-18 | 2016-10-01 | Atezolizumab | 02 | N | 320009263 | PACLITAXEL |
| 320003938 | 320002414 | 1.45 | 79.9 | Curative (C) | 2017-12-13 | 2017-12-18 | CISPLATIN + GEMCITABINE | N | N | 320009322 | OXALIPLATIN + MDG |
| 320003939 | 320002414 | 1.57 | 76.2 | Palliative (P) | 2018-08-23 | 2018-08-26 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 320009322 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 320003940 | 320002414 | 1.72 | 85.6 | Palliative (P) | 2015-11-06 | 2015-11-26 | Ipilimumab | 02 | null | 320009322 | CAPECITABINE + CISPLATIN |
| 320003941 | 320002414 | 1.77 | 97 | Palliative (P) | 2018-02-15 | 2018-04-08 | Cisplatin + Doxorubicin | N | N | 320009322 | CARBO + FLUOROURACIL |
| 320003942 | 320002414 | 1.79 | 76.1 | Neo-adjuvant (N) | 2018-09-25 | 2018-10-04 | EOX | null | N | 320009322 | CETUXIMAB + CISPLATIN + FU |
| 320003943 | 320002414 | 1.74 | 83 | Palliative (P) | 2016-03-24 | 2016-04-12 | Cisplatin + Docetaxel +Fluorouracil | N | N | 320009322 | CAPECITABINE + OXALIPLATIN |
| 320003944 | 320002415 | 1.68 | 83.4 | null | null | 2017-05-23 | Carboplatin + Etoposide iv&po | null | null | 320009509 | CETUXIMAB + CISPLATIN + FU |
| 320003945 | 320002415 | 1.65 | 75.3 | Palliative (P) | 2018-04-04 | 2018-04-05 | CARBOPLATIN + ETOPOSIDE | null | N | 320009509 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003946 | 320002415 | 1.68 | 89.4 | Palliative (P) | null | 2014-03-05 | Gemcitabine + Capecitabine | null | null | 320009509 | mEOC TRIAL |
| 320003947 | 320002416 | 1.5 | 68.6 | Palliative (P) | 2014-12-06 | 2015-01-05 | Cisplatin + Docetaxel +Fluorouracil | N | N | 320009599 | CISPLATIN + ETOPOSIDE |
| 320003948 | 320002416 | 1.56 | 68 | Palliative (P) | 2017-11-29 | 2017-11-29 | Cetuximab +Cisplatin + FU (Cycle 1) | 02 | N | 320009599 | CAPECITABINE + CARBOPLATIN |
| 320003949 | 320002417 | null | 78.7 | Palliative (P) | 2014-07-11 | 2014-08-01 | CAPECITABINE + RT | N | N | 320009627 | PEMBROLIZUMAB |
| 320003950 | 320002418 | null | 64.4 | Not known (9) | 2017-01-20 | 2017-01-23 | Capecitabine | null | null | 320009658 | CARBO + FLUOROURACIL |
| 320003951 | 320002418 | 1.74 | 80 | Palliative (P) | 2016-03-05 | 2017-03-12 | CTD | N | N | 320009658 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003952 | 320002419 | null | null | Curative (C) | 2017-08-22 | 2017-08-28 | OCTREOTIDE | N | N | 320009704 | CISPLATIN + GEMCITABINE |
| 320003953 | 320002420 | 1.59 | 75.4 | Palliative (P) | 2016-07-23 | 2016-07-23 | Carbo F | N | N | 320009721 | CARBOPLATIN + PEMETREXED |
| 320003954 | 320002421 | 1.7 | 62.3 | Not known (9) | 2016-06-22 | 2016-06-22 | Capecitabine + Cisplatin | N | N | 320009740 | CARBOPLATIN + ETOPOSIDE |
| 320003955 | 320002422 | 1.65 | 58.8 | Palliative (P) | 2015-10-03 | 2015-10-07 | CAPECITABINE + CARBOPLATIN + Cetuximab | 2 | N | 320009745 | CISPLATIN + GEMCITABINE |
| 320003956 | 320002422 | 1.75 | 75 | Curative (C) | 2018-03-31 | 2018-03-31 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | Y | 320009745 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003957 | 320002422 | 1.7 | 66.7 | Palliative (P) | 2013-08-03 | 2013-08-04 | Bendamustine+Rituximab (1st Course) | 02 | N | 320009745 | CETUXIMAB |
| 320003958 | 320002423 | 1.72 | 74.4 | Adjuvant (A) | 2018-08-21 | 2018-09-03 | NIVOLUMAB | 2 | N | 320009900 | CARBO + FLUOROURACIL |
| 320003959 | 320002424 | 1.7 | 66 | Palliative (P) | 2015-08-27 | 2015-09-04 | POUT TRIAL | Y | N | 320009937 | FLUOROURACIL + MITOMYCIN + RT |